Director, International Market Access, Neuroscience

Director, International Market Access, Neuroscience Full-time Company Description About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Job Description The International Market Access & Pricing (IMAP) Team leads the market access strategies and planning for pipeline as well as on market products. This role will leverage your clinical understanding, expertise of Evidence Based Medicine, alongside deep global payer knowledge, and competitive insights to shape Phase II/III clinical development programs for pre-launch compounds. IMAP director, PD and Psychosis reports to the VP IMAP, Neuroscience and is accountable for the following: Develop the Global Integrated Access Strategy (IAS) for the Parkinson’s Disease (including Produodopa, Duodopa and Tavapadon) and Psychosis (primarily Emraclidine) portfolio focused on Pricing, Reimbursement and Access (PRA) consistent with the commercial strategy Lead the VAT on creation/maintenance of core payer materials, support of HTA submissions, and optimization of payer evidence generation Identify/manage competitive opportunities/threats from a market access perspective for the Psychiatry and Parkinson’s portfolio Lead the development of Global IASs for assets within the pipeline, notably within disease areas such as depression, bipolar, and schizophrenia Develop/maintain the Payer Value Story (consistent with the Brand Story) for all assets/indications in assigned portfolio Lead team of direct reports to develop compelling core Payer materials based on deep payer insights Assessing/challenging key market access assumptions as part of the Financial Planning Process (LRP/Plan) Collaboratively works with Area and Affiliates to customize approaches Key Responsibilities Include: The ideal candidate will support the global effort to integrate payer value messages for the assigned portfolio (i.e. Parkinson’s and Psychosis) into our clinical and evidence-base assessments and develop key market access deliverables in line with Abbvie’ s PIVOTAL PRA Excellence framework and the asset playbook. At appropriate, ensure Global, Area and Affiliate implementation of the Abbvie launch readiness to achieve PRA. Focus will be on all International markets (EU5, CA, BR, RU, CH, JP) Provide input into clinical development programs to ensure endpoints (i.e., clinical, economic and humanistic outcomes) are incorporated that will optimize price, reimbursement and ultimately patient access globally. Proactively ensure reimbursement considerations are incorporated into global market access strategy as well as multi-functional therapeutic and product assessments throughout key clinical development milestones and strategic commercial decisions. Generate initial global payer value propositions for new products that are aligned with the product’s total emerging value proposition (physicians, payers, and patients) and the product’s target product profile (TPP). Collaborate with GHEOR, Clinical Evidence & Outcomes (CE&O) team, policy, International Marketing & Commercial Operations, Pipeline Commercial Strategy, Area market access and other